Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors

NCT05538676 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-02-13

No results posted yet for this study

Summary

Recently, new high-dose radiation therapy \[e.g., boron neutron capture therapy (BNCT)\] absorbed into the tumor tissue has been applied to treat patients with solid tumors. Here we examine and describe how to evaluate the biological activity of tumors using positron emission tomography (PET) with fluoride-labeled boronophenylalanine (F-BPA) as a tracer.

Conditions

  • Solid Tumor, Adult

Interventions

DIAGNOSTIC_TEST

BPA-PET imaging

PET imaging

Sponsors & Collaborators

  • Xiaohua Zhu

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-26
Primary Completion
2023-08-25
Completion
2025-08-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538676 on ClinicalTrials.gov